Original release date: April 12, 2023
Access to this course expires on: February 9, 2026 at 11:59 PM Pacific Time
CME 16.25

Course Description
Pathologists are generally unfamiliar with a variety of entities in lung, pleural, cardiac and mediastinal pathology, leading to diagnostic errors and creating practice gaps requiring attention. The panorama covered in this interactive microscopy course includes interstitial lung disease, lung infections, pulmonary vasculitis, mesothelial proliferations, mediastinal neoplasia, lung allograft rejection and mimics, heart transplant rejection and distinction from mimics, best practices for optimal triage of lung cancer samples for molecular testing, the cytology of pleural effusions, criteria for aortic vasculitis and other large vessel pathology, recognition of heart valvular pathology, criteria for diagnosis of giant cell arteritis, native heart biopsy interpretation and thoracic soft tissue neoplasms. This faculty ensemble has the professional experience to improve your practice with confidence. You will see cases that make an indelible impression. Breathe easy: this is USCAP, at the heart of education.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Establish the criteria for diagnosis of a variety of areas in pulmonary pathology
• Establish criteria for the diagnosis of mesothelioma and benign mesothelial proliferations
• Provide pathologists with the tools to interpret post-transplant heart and lung biopsy specimens
• Establish criteria for the diagnosis of malignant and benign mediastinal lesions
• Help pathologists be able to provide clinically meaningful diagnoses of native heart endomyocardial biopsy specimens

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 16.25 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Henry D. Tazelaar, MD, Andrew Churg, MD, PhD, Brandon T. Larsen, MD, PhD, Anja C. Roden, MD, Maxwell L. Smith, MD

The following IM coordinator reported no relevant financial relationships: Andrew Folpe, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. Learners can now self-submit CME on all earned certificates. View and print your certificates by clicking here.

USCAP members receive a discount on all e-Learning courses. Not A Member? Click Here to sign up today.